Login
欢迎访问铜陵市医学科学研究院网站!
我要投稿 请登录 免费注册 安全退出

您现在的位置是: 首页 > 博士后工作站 > 在站博士后

在站博士后

Zunera Khalid

2025-10-30 在站博士后 加入收藏
研究方向生物信息学、计算生物学和癌症基因组学;大规模多组学数据(包括全外显子测序(WES)、全基因组测序(WGS)和转录组测序(RNA-seq))的分析;癌症

 研究方向:

生物信息学、计算生物学和癌症基因组学大规模多组学数据(包括全外显子测序(WES)、全基因组测序(WGS)和转录组测序(RNA-seq))的分析癌症类型中的驱动突变、拷贝数变异和结构变异新抗原发现与 T 细胞表位预测基因组学、免疫学与计算建模

学习与工作经历:

2011.09-2015.07巴基斯坦COMSATS大学    生物信息学  本科

2015.09-2017.07巴基斯坦Quaid-i-Azam大学   生物信息学  硕士

2018.09-2024.03中国科学技术大学        生物信息学  博士
 

2025.06-至今:铜陵市人民医院-中国科学技术大学  博士后

 

研究成果 :

1. Khalid, Zunera, Amen Shamim, Mohamed J. Saadh, Ahmed Alafnan, Mohd Alaraj, Muhammad Hassan Butt, and Tehreem Ashraf. "Identification of Potential Inhibitors against Corynebacterium diphtheriae MtrA Response Regulator Protein; An in-silico Drug Discovery Approach." Journal of Molecular Graphics and Modelling (2024): 108858. (Q2, IF 3).

2. Nazir, Farah, Arnaud John Kombe Kombe, Zunera Khalid, Shaheen Bibi, Hongliang Zhang, Songquan Wu, and Tengchuan Jin. "SARS-CoV-2 replication and drug discovery." Molecular and Cellular Probes 77 (2024): 101973. (Q3, IF 3).

3. Chen, Yu-Lei, Xin-Xin Xie, Peiyi Zheng, Chenchen Zhu, Huan Ma, Zunera Khalid et al. Selection, identification and crystal structure of shark-derived single-domain antibodies against a green fluorescent protein. International Journal of Biological Macromolecules, (2023); 247: 125852. (Q1, IF 8.5).

4. Mengist, Hylemariam Mihiretie, Zunera Khalid, Fentahun Adane. In silico screening of Potential SARS-CoV-2 Main Protease Inhibitors from Thymus schimperi. Advances and Applications in Bioinformatics and Chemistry, (2023): 1-13. (Q1)

5. Ali, Atif, Zunera Khalid, and Jamaan S. Ajarem. "Wastewater treatment by using microalgae: Insights into fate, transport, and associated challenges." Chemosphere 338 (2023): 139501. (Q1).

6. Khalid, Zunera, Ma Huan, Muhammad Sohail Raza, Misbah Abbas, Zara Naz, Arnaud John KOMBE KOMBE, Weihong Zeng, Hongliang He, and Tengchuan Jin. "Identification of novel therapeutic candidates against SARS-COV-2 infections: an application of RNA sequencing towards mRNA-based nanotherapeutics." Frontiers in Microbiology: (2022): 2432. (Q1, IF 4.5).

7. Khalid, Zunera, Yulei Chen, Du Yu, Misbah Abbas, Ma Huan, Zara Naz, Hylemariam Mihiretie Mengist, Min-jie Cao, and Tengchuan Jin. "IgNAR antibody: Structural features, diversity and applications." Fish & Shellfish Immunology (2022). (Q1, IF 3.9).

8. Nazir, Farah, Qingyu Cheng, Zunera Khalid, and Tengchuan Jin. "SARS-CoV-2 specific T-cell receptors and insights into Infection, Immunity and Vaccine Design." Journal of Applied Virology 11, no. 2 (2022): 9-31.

9. Mangrio, Ghulam Rasool, Apichit Maneengam, Zunera Khalid, Tassadaq Hussain Jafar, Ghulam Qadir Chanihoon, Rayan Nassani, and Ahsanullah Unar. "RP-HPLC Method Development, Validation, and Drug Repurposing of Pharmaceutical Dosage Form: A Multidimensional Sofosbuvir Study." Environmental Research 212 (2022): 113282. (Q1, IF 7.7).

10. Chanihoon, Ghulam Qadir, Zunera Khalid, Hassan Imran Afridi, Tassadaq Hussain Jafar, Abdelmohsen A. Nassani, Ahsanullah Unar, and Mohamed Haffar. "Determining the level of essential elements in patients with Ewing Sarcoma: A correlation." Environmental Research 211 (2022): 113035. (Q1, IF 7.7).

11. Hussain, Annam, Maham Shahbaz, Maria Tariq, Muhammad Ibrahim, Xianxian Hong, Faryal Naeem, Zunera Khalid, Hafiz Muhammad Zeeshan Raza, Zhu Bo, and Li Bin. "Genome re-seqeunce and analysis of Burkholderia glumae strain AU6208 and evidence of toxoflavin: A potential bacterial toxin." Computational Biology and Chemistry 86 (2020): 107245. (Q2, IF 3.1).

12. Khalid, Zunera, Sajjad Ahmad, Saad Raza, and Syed Sikander Azam. "Subtractive proteomics revealed plausible drug candidates in the proteome of multi-drug resistant Corynebacterium diphtheriae." Meta Gene 17 (2018): 34-42.

13. Khalid, Zunera, and Shazia Mannan. "Revealing potential drug targets against Proto-oncogene Wnt10B by comparative molecular docking." Pure and Applied Biology (PAB) 7, no. 2 (2018): 565-574.

 


首页下 AD宣传图